Hemorrhoids Market Report 2025

The hemorrhoids market size has grown strongly in recent years. It will grow from $2.76 billion in 2024 to $2.95 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period can be attributed to the rising geriatric population, an increasing number of clinical trials, the growing burden of target diseases, higher demand for surgical interventions, and the rising prevalence of hemorrhoids.

The hemorrhoids market size is expected to see strong growth in the next few years. It will grow to $3.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth during the forecast period can be attributed to the rising demand for over-the-counter (OTC) products, an increase in the prevalence of hemorrhoids, a growing preference for minimally invasive hemorrhoid surgery, higher healthcare spending, and increasing awareness of the disease. Key trends expected in this period include advanced surgical interventions, improvements in diagnostic tools, the adoption of personalized medicine, the development of innovative devices, and advancements in drug development.

The growing demand for over-the-counter (OTC) products is expected to drive the growth of the hemorrhoids market. OTC products are available for purchase without a prescription and are easily accessible, contributing to their increasing popularity. This rise in demand can be attributed to consumers’ preference for self-care, convenience, and cost-effectiveness. OTC products, including creams, ointments, suppositories, and wipes, help alleviate hemorrhoid symptoms such as pain, itching, swelling, and inflammation. For example, in July 2023, the Proprietary Association of Great Britain (PAGB), a UK-based trade association, reported that in 2022, UK OTC manufacturers produced $5.55 billion worth of products annually, with approximately $3.61 billion in exports. This demonstrates the significant demand for OTC products, which is contributing to the growth of the hemorrhoids market.

Leading companies in the hemorrhoids market are innovating with minimally invasive treatments to improve patient comfort, reduce recovery time, and enhance clinical outcomes. Minimally invasive hemorrhoid treatments involve advanced techniques that minimize tissue damage, pain, and recovery time compared to traditional hemorrhoidectomy methods. For example, in December 2023, Medical Fintech Innovations B.V., a Netherlands-based technology company, introduced the HemWell GEN 2. This next-generation device offers the Hemwellectomy procedure, an electrosurgical solution for hemorrhoids designed to be less painful than traditional methods. This innovation promotes faster recovery, allowing patients to return to their daily activities more quickly.

In March 2024, Karo Healthcare AB, a healthcare company based in Sweden, acquired the OTC brand Proctosedyl, a hemorrhoid treatment, from Bayer AG for an undisclosed amount. This acquisition strengthens Karo Healthcare’s position in the Italian market, expands its digestive health portfolio, and improves consumer access to trusted hemorrhoid treatments, giving the company a competitive edge in the region. Bayer AG, a Germany-based pharmaceutical company, specializes in manufacturing OTC drugs for a variety of conditions.

Major players in the hemorrhoids market are Johnson & Johnson, Bayer AG, Abbott Laboratories, Medtronic Plc, Takeda Pharmaceutical Company, Medline Industries Inc., Boston Scientific Corporation, Church & Dwight Co. Inc., Dr. Reddy’s Laboratories Ltd, Integra LifeSciences Corporation, Glenmark Pharmaceuticals, CONMED Corporation, B. Braun Melsungen AG, Sebela Pharmaceuticals, AMATO PHARMACEUTICAL PRODUCTS LTD, Sklar Surgical Instruments, A.M.I. GmbH, Citius Pharmaceuticals, Privi Medical, and Surkon Medical Co. Ltd.

North America was the largest region in the hemorrhoids market in 2024. The regions covered in hemorrhoids report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the hemorrhoids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Hemorrhoids are swollen and inflamed veins in the rectum and anus, often causing discomfort, pain, itching, and bleeding. They typically result from increased pressure caused by straining during bowel movements, pregnancy, or prolonged sitting.

The primary types of hemorrhoids are internal, external, and mixed. Internal hemorrhoids develop inside the rectum and are generally painless due to the lack of pain-sensitive nerves in that area. However, they may cause bleeding during bowel movements and, in some cases, protrude outside the anus. Treatment options for hemorrhoids include medications, minimally invasive procedures, and surgical interventions. Care is provided in hospitals, clinics, ambulatory surgery centers (ASCs), and homecare settings, with medications distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The hemorrhoids market research report is one of a series of new reports that provides hemorrhoids market statistics, including the hemorrhoids industry's global market size, regional shares, competitors with a hemorrhoids market share, detailed hemorrhoids market segments, market trends and opportunities, and any further data you may need to thrive in the hemorrhoids industry. This hemorrhoids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hemorrhoids market consists of revenues earned by entities by providing medical services such as digital rectal exams, anoscopy, rubber band ligation, sclerotherapy, and hemorrhoidectomy or stapled hemorrhoidopexy. The market value includes the value of related goods sold by the service provider or included within the service offering. The hemorrhoids market also includes sales of creams, ointments, gels, pain relievers, anti-inflammatory drugs, and pre-moistened pads or wipes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.